nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0935	0.111	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—ankylosing spondylitis	0.0855	0.102	CbGbCtD
Buprenorphine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0518	0.0617	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0504	0.0601	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—ankylosing spondylitis	0.0467	0.0556	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0445	0.053	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—ankylosing spondylitis	0.0375	0.0447	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0345	0.0411	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0345	0.0411	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—ankylosing spondylitis	0.0334	0.0398	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—ankylosing spondylitis	0.0289	0.0345	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—ankylosing spondylitis	0.0285	0.034	CbGbCtD
Buprenorphine—ABCB1—Prednisone—ankylosing spondylitis	0.0269	0.0321	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0266	0.0318	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0258	0.0308	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0249	0.0296	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0208	0.0248	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0202	0.0241	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0173	0.0207	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0173	0.0206	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0171	0.0204	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0168	0.02	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—ankylosing spondylitis	0.0161	0.0192	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0158	0.0189	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—ankylosing spondylitis	0.0135	0.0161	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0101	0.012	CbGbCtD
Buprenorphine—Naloxone—TLR4—ankylosing spondylitis	0.00801	1	CrCbGaD
Buprenorphine—Vertigo—Betamethasone—ankylosing spondylitis	0.000263	0.00172	CcSEcCtD
Buprenorphine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000263	0.00172	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000263	0.00172	CcSEcCtD
Buprenorphine—Syncope—Betamethasone—ankylosing spondylitis	0.000263	0.00172	CcSEcCtD
Buprenorphine—Syncope—Dexamethasone—ankylosing spondylitis	0.000263	0.00172	CcSEcCtD
Buprenorphine—Infection—Triamcinolone—ankylosing spondylitis	0.000262	0.00171	CcSEcCtD
Buprenorphine—Sweating—Methotrexate—ankylosing spondylitis	0.000262	0.00171	CcSEcCtD
Buprenorphine—Infection—Methylprednisolone—ankylosing spondylitis	0.000261	0.00171	CcSEcCtD
Buprenorphine—Shock—Triamcinolone—ankylosing spondylitis	0.000259	0.0017	CcSEcCtD
Buprenorphine—Insomnia—Prednisolone—ankylosing spondylitis	0.000259	0.00169	CcSEcCtD
Buprenorphine—Shock—Methylprednisolone—ankylosing spondylitis	0.000259	0.00169	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000258	0.00169	CcSEcCtD
Buprenorphine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000258	0.00169	CcSEcCtD
Buprenorphine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000257	0.00168	CcSEcCtD
Buprenorphine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000255	0.00167	CcSEcCtD
Buprenorphine—Erythema—Prednisone—ankylosing spondylitis	0.000255	0.00167	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—ankylosing spondylitis	0.000255	0.00167	CcSEcCtD
Buprenorphine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000255	0.00167	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000254	0.00166	CcSEcCtD
Buprenorphine—Convulsion—Betamethasone—ankylosing spondylitis	0.000254	0.00166	CcSEcCtD
Buprenorphine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000254	0.00166	CcSEcCtD
Buprenorphine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000253	0.00165	CcSEcCtD
Buprenorphine—Hypertension—Betamethasone—ankylosing spondylitis	0.000253	0.00165	CcSEcCtD
Buprenorphine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000249	0.00163	CcSEcCtD
Buprenorphine—Myalgia—Betamethasone—ankylosing spondylitis	0.000249	0.00163	CcSEcCtD
Buprenorphine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000248	0.00163	CcSEcCtD
Buprenorphine—Anxiety—Betamethasone—ankylosing spondylitis	0.000248	0.00163	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—ankylosing spondylitis	0.000246	0.00161	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000246	0.00161	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000246	0.00161	CcSEcCtD
Buprenorphine—Pain—Prednisolone—ankylosing spondylitis	0.000245	0.0016	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000243	0.00159	CcSEcCtD
Buprenorphine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000242	0.00158	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—ankylosing spondylitis	0.00024	0.00157	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00157	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00024	0.00157	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000239	0.00157	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000239	0.00156	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—ankylosing spondylitis	0.000239	0.00156	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000239	0.00156	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—ankylosing spondylitis	0.000239	0.00156	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000238	0.00156	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000238	0.00155	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—ankylosing spondylitis	0.000237	0.00155	CcSEcCtD
Buprenorphine—Infection—Betamethasone—ankylosing spondylitis	0.000237	0.00155	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000237	0.00155	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000237	0.00155	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000236	0.00154	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000236	0.00154	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000236	0.00154	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—ankylosing spondylitis	0.000235	0.00154	CcSEcCtD
Buprenorphine—Shock—Betamethasone—ankylosing spondylitis	0.000235	0.00154	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000235	0.00154	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000234	0.00153	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000234	0.00153	CcSEcCtD
Buprenorphine—Agitation—Prednisone—ankylosing spondylitis	0.000234	0.00153	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000233	0.00153	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000233	0.00153	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—ankylosing spondylitis	0.000233	0.00152	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000232	0.00152	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000231	0.00151	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000231	0.00151	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000231	0.00151	CcSEcCtD
Buprenorphine—Malaise—Prednisone—ankylosing spondylitis	0.00023	0.0015	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—ankylosing spondylitis	0.000229	0.0015	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000229	0.0015	CcSEcCtD
Buprenorphine—Syncope—Prednisone—ankylosing spondylitis	0.000229	0.0015	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000228	0.00149	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—ankylosing spondylitis	0.000228	0.00149	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000228	0.00149	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—ankylosing spondylitis	0.000228	0.00149	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000227	0.00149	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000227	0.00149	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000227	0.00148	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—ankylosing spondylitis	0.000225	0.00147	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000224	0.00147	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000223	0.00146	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—ankylosing spondylitis	0.000223	0.00146	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000222	0.00145	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000221	0.00145	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—ankylosing spondylitis	0.000221	0.00145	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000221	0.00144	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—ankylosing spondylitis	0.00022	0.00144	CcSEcCtD
Buprenorphine—Chills—Methotrexate—ankylosing spondylitis	0.00022	0.00144	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000218	0.00142	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000218	0.00142	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—ankylosing spondylitis	0.000217	0.00142	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—ankylosing spondylitis	0.000217	0.00142	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000217	0.00142	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000217	0.00142	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—ankylosing spondylitis	0.000216	0.00142	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—ankylosing spondylitis	0.000216	0.00141	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000216	0.00141	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000216	0.00141	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000215	0.00141	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000215	0.0014	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000215	0.0014	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—ankylosing spondylitis	0.000215	0.0014	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000215	0.0014	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—ankylosing spondylitis	0.000213	0.00139	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000213	0.00139	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000211	0.00138	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00021	0.00138	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00021	0.00138	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000209	0.00137	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000209	0.00137	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000209	0.00137	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Oedema—Prednisone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000208	0.00136	CcSEcCtD
Buprenorphine—Infection—Prednisone—ankylosing spondylitis	0.000207	0.00135	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000206	0.00135	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000206	0.00135	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—ankylosing spondylitis	0.000206	0.00135	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000206	0.00135	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—ankylosing spondylitis	0.000206	0.00135	CcSEcCtD
Buprenorphine—Shock—Prednisone—ankylosing spondylitis	0.000205	0.00134	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—ankylosing spondylitis	0.000204	0.00134	CcSEcCtD
Buprenorphine—Pain—Betamethasone—ankylosing spondylitis	0.000204	0.00134	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000204	0.00134	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—ankylosing spondylitis	0.000203	0.00133	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—ankylosing spondylitis	0.000202	0.00132	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000201	0.00132	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000201	0.00131	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—ankylosing spondylitis	0.000198	0.0013	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000198	0.00129	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000197	0.00129	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000197	0.00129	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000195	0.00128	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000195	0.00128	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000194	0.00127	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000194	0.00127	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—ankylosing spondylitis	0.000192	0.00126	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—ankylosing spondylitis	0.000192	0.00125	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—ankylosing spondylitis	0.00019	0.00124	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00019	0.00124	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00019	0.00124	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000189	0.00124	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000189	0.00123	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—ankylosing spondylitis	0.000188	0.00123	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000187	0.00122	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000186	0.00122	CcSEcCtD
Buprenorphine—Cough—Methotrexate—ankylosing spondylitis	0.000186	0.00122	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000186	0.00122	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—ankylosing spondylitis	0.000185	0.00121	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000183	0.0012	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—ankylosing spondylitis	0.000181	0.00119	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000181	0.00119	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—ankylosing spondylitis	0.000181	0.00119	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000181	0.00118	CcSEcCtD
Buprenorphine—Rash—Prednisolone—ankylosing spondylitis	0.000181	0.00118	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00018	0.00118	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00018	0.00118	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00018	0.00118	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—ankylosing spondylitis	0.000179	0.00117	CcSEcCtD
Buprenorphine—Headache—Prednisolone—ankylosing spondylitis	0.000179	0.00117	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—ankylosing spondylitis	0.000179	0.00117	CcSEcCtD
Buprenorphine—Constipation—Prednisone—ankylosing spondylitis	0.000178	0.00116	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—ankylosing spondylitis	0.000175	0.00115	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000174	0.00114	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000174	0.00114	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000174	0.00114	CcSEcCtD
Buprenorphine—Infection—Methotrexate—ankylosing spondylitis	0.000173	0.00113	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000172	0.00112	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—ankylosing spondylitis	0.000171	0.00112	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000171	0.00112	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000171	0.00112	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00017	0.00111	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—ankylosing spondylitis	0.00017	0.00111	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000169	0.00111	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—ankylosing spondylitis	0.000169	0.00111	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000169	0.00111	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000168	0.0011	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000167	0.0011	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000167	0.00109	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—ankylosing spondylitis	0.000166	0.00109	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000166	0.00109	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—ankylosing spondylitis	0.000166	0.00108	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—ankylosing spondylitis	0.000166	0.00108	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000166	0.00108	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—ankylosing spondylitis	0.000165	0.00108	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—ankylosing spondylitis	0.000165	0.00108	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—ankylosing spondylitis	0.000165	0.00108	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000165	0.00108	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000165	0.00108	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000164	0.00107	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000164	0.00107	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—ankylosing spondylitis	0.000163	0.00106	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000158	0.00104	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000158	0.00103	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—ankylosing spondylitis	0.000158	0.00103	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—ankylosing spondylitis	0.000157	0.00103	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—ankylosing spondylitis	0.000156	0.00102	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000156	0.00102	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000156	0.00102	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000155	0.00101	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—ankylosing spondylitis	0.000155	0.00101	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000153	0.001	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000153	0.001	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000152	0.000994	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—ankylosing spondylitis	0.000152	0.000994	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000151	0.000989	CcSEcCtD
Buprenorphine—Rash—Betamethasone—ankylosing spondylitis	0.000151	0.000986	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—ankylosing spondylitis	0.000151	0.000986	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000151	0.000985	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000151	0.000985	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00015	0.000982	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—ankylosing spondylitis	0.00015	0.000981	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—ankylosing spondylitis	0.00015	0.000979	CcSEcCtD
Buprenorphine—Headache—Betamethasone—ankylosing spondylitis	0.00015	0.000979	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—ankylosing spondylitis	0.000149	0.000977	CcSEcCtD
Buprenorphine—Pain—Methotrexate—ankylosing spondylitis	0.000149	0.000973	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—ankylosing spondylitis	0.000147	0.000963	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000143	0.000938	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000142	0.000932	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000142	0.00093	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—ankylosing spondylitis	0.000142	0.000929	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—ankylosing spondylitis	0.000142	0.000929	CcSEcCtD
Buprenorphine—Urticaria—Methotrexate—ankylosing spondylitis	0.000138	0.000904	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—ankylosing spondylitis	0.000138	0.0009	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000138	0.000899	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000138	0.000899	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—ankylosing spondylitis	0.000132	0.000866	CcSEcCtD
Buprenorphine—Rash—Prednisone—ankylosing spondylitis	0.000131	0.000858	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—ankylosing spondylitis	0.000131	0.000858	CcSEcCtD
Buprenorphine—Headache—Prednisone—ankylosing spondylitis	0.00013	0.000853	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000128	0.000838	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—ankylosing spondylitis	0.000125	0.000816	CcSEcCtD
Buprenorphine—Nausea—Prednisone—ankylosing spondylitis	0.000124	0.000809	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—ankylosing spondylitis	0.000123	0.000805	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000119	0.000779	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—ankylosing spondylitis	0.000115	0.000752	CcSEcCtD
Buprenorphine—Vomiting—Methotrexate—ankylosing spondylitis	0.000111	0.000723	CcSEcCtD
Buprenorphine—Rash—Methotrexate—ankylosing spondylitis	0.00011	0.000717	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00011	0.000717	CcSEcCtD
Buprenorphine—Headache—Methotrexate—ankylosing spondylitis	0.000109	0.000713	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—ankylosing spondylitis	0.000103	0.000676	CcSEcCtD
